Overview

Efficacy Investigation Study of Olopatadine Hydrochloride Ophthalmic Solution Using OHIO Chamber in Patients With Seasonal Allergic Rhinitis (SAR)

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy of olopatadine 0.1% using the OHIO Chamber in patients with seasonal allergic conjunctivitis.
Phase:
Phase 4
Details
Lead Sponsor:
Alcon Research
Treatments:
Olopatadine Hydrochloride
Ophthalmic Solutions
Tranilast